The SteriPlas can be used to treat a variety of areas on the body

We are proud have been able to treat a wide scale of body areas. Our clinical evidence ranges across a multitude of conditions and areas of the body including the foot, leg, arms, head, neck, scalp, hands, axilla and even groin. All wounds/lesions present in these areas of the body had shown positive responses to treatment with the Adtec SteriPlas.

 

We are always open to treating new conditions and welcome any study proposals that you have. If you would like to get the Adtec SteriPlas in your clinic or hospital, please contact us at info@adtecplasma.com where one of our team members will assist you with the delivery.

 

 


The Adtec SteriPlas featured in another Actinic Keratoses publication

We would like to congratulate Dr Mariachiara Arisi and her team at The Department of Dermatology, Brescia Hospital in Italy for their latest publication: “Cold Atmospheric Plasma (CAP) for the Treatment of Actinic Keratosis and Skin Field Cancerization: Clinical and High-Frequency Ultrasound Evaluation”.

 

This publication features the Adtec SteriPlas and further demonstrates its efficacy for treating complicated Actinic Keratoses (AK) lesions. All patient enrolled into this study had previously shown resistance or intolerance to conventional field-directed therapies. The results of the study show how all patients who received treatment with the Adtec SteriPlas had significantly reduced AK lesions with the benefit of no side effects observed, quite the opposite for conventional therapies that often bear undesirable side effects. The Adtec SteriPlas continues to be a favoured treatment alternative for actinic keratoses by continuing to be faster-acting, safer and reliable.

 

You can read the full publication here: https://link.springer.com/article/10.1007%2Fs13555-021-00514-y

 


Deep Sternum Surgical Site Infections (DSSIs)

 

Deep sternal surgical site infections (DSSIs) are a still a severe complication after cardiac surgery. The mortality estimated range is between 15%-40% of all cases. In addition to the significantly extended hospitalization, there is a significant cost burden with a calculated cost of € 36,000 for a single DSSI case.

The use of the Adtec SteriPlas for these complicated conditions has been actively documented as better managing the chronic infections, reducing hospitalization times and cost but more importantly it has shown to decrease the mortality rate. Our medical device has been praised as a tissue and life saving medical device.


SteriPlas' patented 6 electrode plasma system

Did you know our plasma chamber features a patented 6 electrode plasma torch system? This is where the cold plasma is generated before it is propelled with the gas flow over the treatment site. Our 60+ peer reviewed clinical studies have shown that accelerated healing in stalled and non-healing wounds/skin conditions can be achieved with no side effects reported.